Benzinga | Nov 4, 2020 04:36PM EST

ACADIA Pharmaceuticals Q3 EPS $(0.54) Misses $(0.38) Estimate, Sales $120.60M Beat $118.82M Estimate

ACADIA Pharmaceuticals (NASDAQ:ACAD) reported quarterly losses of $(0.54) per share which missed the analyst consensus estimate of $(0.38) by 42.11 percent. This is a 86.21 percent decrease over losses of $(0.29) per share from the same period last year. The company reported quarterly sales of $120.60 million which beat the analyst consensus estimate of $118.82 million by 1.50 percent. This is a 27.50 percent increase over sales of $94.59 million the same period last year.